Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Greenway Medical Merger Agreement & One Hedge Fund’s Massive Stake

Greenway Medical merger: Greenway Medical Technologies, Inc. (NYSE:GWAY) recently entered into a merger agreement, according to a filing from one of its shareholders, Pamlico Capital, which holds 17.8% of its shares. Under the terms of the agreement VCG Holdings and Crestview Acquisition Corp will purchase all of the outstanding shares of Greenway Medical Technologies for a price of $20.35 per share.

Greenway Medical Technologies, Inc.

Pamlico Capital owns 5.3 million shares of Greenway Medical Technologies, with the value of the stake amounting to $107.8 million. For its fiscal year ended June 30, Greenway Medical reported a net loss of $5.1 million, versus an income of $2.9 million in the previous fiscal year. For FY2014, the company forecasted a net loss between $6.3 million and $5 million, Greenway said in a statement.

In addition to Pamlico, some hedge funds also disclosed ownership of Greenway Medical Technologies in the latest round of 13F filings. As follows, CR Intrinsic Investors, an SAC Capital Subsidiary, owned 307,300 shares, followed by Chuck Royce’s Royce & Associates with 150,000 shares, and D. E. Shaw’s D. E .Shaw & Co. Check back here for more updates on the Greenway Medical merger.

Recommended Reading:

Hedge Fund News: Carl Icahn, Bill Ackman & Man Group’s Sell Ratings

The Scoop on Bill Ackman’s Air Products & Chemicals Bombshell

Is RTI Surgical a Good Buy? The Newly-Formed Hedge Fund Thinks So

Disclosure: none

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.